Day 1 Program

Special Session 2: Lobular Breast Cancer Updates 

Day 1: December 9, 2025

11:00 AM–12:30 PM CST

Stars at Night 3-4

Session Details

This special session will provide updates on the classification of breast cancer subtypes, emerging biomarkers with clinical relevance, ongoing debates about the role of chemotherapy, and insights from ILC-specific trials, followed by a patient advocate perspective and panel discussion.

SS2-02

Topic 1: Current updates on diagnostic criteria and classification of special subtypes

Anne Cs Vincent Salomon, Institut Curie, Paris, France

SS2-03

Topic 2: Novel biomarkers with clinical implications

Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium

SS2-04

Topic 3: Controversies in clinical decision making—Is there still a role for chemotherapy?

Otto Metzger, Dana-Farber Cancer Institute, Chestnut Hill, MA

SS2-05

Topic 4: ILC-specific trials—Lessons learned and future designs

Philippe Aftimos, Institut Jules Bordet, Brussels, Belgium

Advocate

Flora Migyanka, Founder President Dynami Foundation, Plymouth, MI